生物醫藥ETF（512290）漲近2%，藥明康德漲近7%
藥明康德漲近7%，邁瑞醫療漲超4%、恆瑞醫藥漲超3.5%，生物醫藥ETF(512290)漲近2%，成交額超7800萬元。過去5天淨流入超1.3億元。
野村東方國際證券認爲，當前醫藥板塊滾動市盈率爲23.5倍，相較於年初的35倍估值進一步迴歸合理區間。近期醫藥板塊表現仍受短期熱點事件影響較大，如新冠藥物研發，核酸檢測常態化以及歐美國家猴痘病毒傳播等。當前上海疫情接近尾聲，北京疫情擴散風險控制良好，醫藥消費復甦可期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Ok